Abstract
Conclusions
The chemotherapeutic effects of 3 thiazol derivatives of sulfanilamide under conditions of experimental streptococcal or pneumococcal infections are definitely superior to those of the parent substance and compare very favorably with those of sulfapyridine. On the basis of the superior margin of safety of sulfathiazol and particularly sulfamethylthiazol, as compared with sulfanilamide and sulfapyridine, these new compounds appear quite promising.
Get full access to this article
View all access options for this article.